安旭生物(688075.SH)发预减，预计2025年年度归母净利润同比减少55.80%到63.08%

Core Viewpoint - Anxue Bio (688075.SH) forecasts a significant decline in net profit for the year 2025, projecting a range of 71 million to 85 million yuan, which represents a decrease of approximately 55.80% to 63.08% compared to the previous year [1] Group 1: Financial Performance - The expected net profit for 2025 is between 71 million and 85 million yuan, down from the previous year's figures by 107.2953 million to 121.2953 million yuan [1] - The year-on-year decline in net profit is projected to be between 55.80% and 63.08% [1] Group 2: Business Operations - The company maintains steady development in its core business operations [1] - To strengthen its long-term competitive advantage in the industry, the company continues to invest strategically in new technology platforms while ensuring the advancement of its existing platforms [1] - Increased expenses are attributed to the expansion of domestic and international markets, as well as the establishment of overseas subsidiaries [1]